SFTPA2 and COVID-19: These findings contribute to our understanding of the role of human SP-A in SARS-CoV-2-induced pathogenesis as an important host defense protein that could attenuate SARS-CoV-2 infectivity and lung pathology while serving as a potential therapeutic component for COVID-19.